Vol. 112, No. 1, 1983 April
BIOCHEMICAL
RESEARCH COMMUNICATIONS
AND BIOPHYSICAL
Pages 250-256
15, 1983
ALTERAWON
OF ADENYLATE CYCLASE ACTIVITY
BY PHOSPHORYLATION AND DEPHOSPHORYLATION Tetsu Second
Received
Akiyama,
Emiko Gotho
and Hiroshi
Department of Biochemistry, Nozawa-1, Setagaya-ku,
February
28,
Ogawara
Meiji College of Pharmacy, Tokyo 154, Japan
1983
Incubation of S49 cell membranes at 0°C resulted in a loss of adenylate cyclase activity, but addition of ATP and ATP regenerating system prevented the decrease of the activity. A non-phosphorylating analogue of ATP, adenyl-5'-yl imidodiphosphate, was less effective than ATP. Treatment of solubilized adenylate cyclase with calf intestine alkaline phosphatase caused the decrease of the activity. Membranes from cyc- S49 mutant cells, which are devoid of guanine nucleotidebinding protein, yielded the same results as membranes from S49 cells, indicating that the catalytic component is involved in the alteration of the enzyme activity by these treatments. These results suggest that phosphorylation and dephosphorylation of the catalytic component may regulate adenylate cyclase activity.
Protein process
phosphorylation of cellular
activity
are
observed
the
case of adenylate
which
fluoride
play
a role
and molybdate
To examine volved tion
in the
ATP, ATP regenerating treatment.
Furthermore,
system, using
under
protein and Mgzt, cyc-
0006-291X/83 $1.50 Cop.vright :G 1983 b-vAcademic Press. Inc. All rights of reproduction in any form reserved.
activity
cyclase,
membranes
by an endogenous
that
that
kinase
suggesting the
250
In
regulation
stimulation
inhibitory reported
of
properties ATP-dependent
the phosphorylation
by ATP may
and dephosphorylation we studied
the
effect
conditions
where
can occur:
i.e.
and the dephosphorylation
S49 mutant
(1,2).
(6).
phosphorylation
of adenylate cell
proposed
and suggested
that
proteins
and dephosphorylation
They recently
cyclase
in the regulatory
and nonenzymatic
to phosphatase
(7-9).
adenylate
the possibility regulation
of enzymatic
et a1.(5)
share
role
have been some reports
is related
cyclase
of S49 mouse lymphoma
phosphorylation
there
Richards
in elevating
an important
by phosphorylation
by molybdate
of adenylate
to play
and a number
cyclase, (3-6).
cyclase
activation
known
to be regulated
by phosphorylation adenylate
is
cells
(lo-13),
are
in-
of incuba-
ATP-dependent incubation
with
by phosphatase we sought
to identi-
Vol
112, PJo. 1, 1983
f y which
BIOCHEMICAL
component
of the
of the adenylate
enzyme activity
presented
AND BIOPHYSICAL
in this
by these
cyclase
system
RESEARCH COMMUNICATIONS
is
involved
The results
treatments.
in the alteration
of these
experiments
are
report. MATERIALS
AND METHODS
Cell culture: 549 wild type and cyc- mutant cells were grown in Dulbecco's modified Eagle's basal medium supplemented with 10% heat-inactivated horse serum in suspension culture. Preparation of plasma membrane was according to Courtneidge et a1.(14). Adenylate cyclase activity was measured by the method of Salomon et a1.(15). Plasma membranes were incubated with ATP as described in the legend to Fig. 1. Phosphatase treatment of solubilized adenylate cyclase: Adenylate cyclase was so-ubilized from plasma membranes (2.3 mg protein/ml) with 1% Triton NlOl in solution A (20 mM Hepes [4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid]-NaOH pH 7.11, 1 mM dithiothreitol, 5 mM MgC12). After incubation for 1 h at O"C, insoluble material was removed by centrifugation at 100,000 x g for 30 min. Extracts were incubated for various times at 0°C with agarose or calf intestine alkaline phosphcltase immobilized on agarose (final concentration: 0.76 units/100 111 reaction mixture). Agarose or immobilized alkaline phosphatase was removed by centrifugation and the adenylate cyclase activity of the supernatant was measured. 32P-labeled plasma membranes were prepared by incubation with 20 mM Pipes [1,4pi.)erazinediethanesulphonic acid]-NaOH pH 7.2, 4 mM MgC12, and [,32P]ATP (7 uM, 63 mCi/pmole) for 20 min at 30°C. 32P-labeled plasma membranes collected by centrifugation at 100,000 x g for 30 min were solubilized and treated with agarose or immobilized alkaline phosphatase as described above. Radioactivity not removed fr)m proteins was measured according to the procedure of Cassel et a1.(16). Immobilized alkaline phosphatase was obtained from Sigma. RESULTS Plasma
membranes
without
ATP,
shown
in Fig.
ing
system
manner.
prepared
l(a),
resulted
did
not
To examine
ljzed
calf
centrifugation. by the treatment
this
activity
the
adenylate
of adenylate
analogue
phosphorylation, immobilized
in a loss
membranes
without
cyclase
activity
incubated
with
(Table
cyclase
adenylate
cyclase
solubilized
with
intestine
alkaline
As shown with
in Fig.
phosphatase,
alkaline
2(a),
alkaline adenylate
phosphatase. 251
various
with
times.
or As
ATP and ATP regeneratin a time-dependent
were
incubated
with
a
imidodiphosphate],
1).
adenylate
and immobilized
incubated
ATP and ATP regenerating
membranes
that
cyclase
were
of ATP, AppNHp [adenyl-5'-yl decreased
possibility
membranes
When plasma
loss.
cells
and MgC12 at 0°C for
of plasma
exhibit
cyclase
system
incubation
plasma
nc'n-phosphorylating adenylate
S49 mouse lymphoma
the ATP regenerating
By contrast,
system
from
activity Triton
NlOl
and after
By contrast,
changed was reacted
incubation
phosphatase cyclase
is
were
activity adenylate
the separated
by dewith solubiby
was decreased cyclase
incu-
Vol. 112, No. 1, 1983 bated
with
agarose
phosphate
from
alone
with
[y32P]ATP
which
from
examined
cyc-
the
and the
variant
alteration
treatment
in the
cells
presence
was similar
by this
which
alkaline
to S49 adenylate
decrease
of the activity
proteins
(Fig.
treatment
described
lack
guanine
cyclase
cyclase.
in Fig.
Phosphatase
3(a),
32P manner.
involved
in the
al-
above,
we prepared
plasma
mem-
protein incubation
cyclase
and
with
activity
response
resulted
was removed
ATP
was assayed
to incubation
treatment
phosphate
alka-
is
by the
the
membrane
immobilized
nucleotide-binding
l(b),
and concurrently
plasma
of
system
Adenylate
in Fig.
with
removal
in a time-dependent
activity
phosphatase.
the
the
As shown
cyclase
treatment
of hy~:~+. As shown
2(b),
was measured.
of adenylate
with
reaction,
and treated
of adenylate
by the
To verify
by this
was solubilized
component
RESEARCH COMMUNICATIONS
of activity.
proteins
was removed
of the activity
brane
no decrease
membrane
of proteins
To identify teration
AND BIOPHYSICAL
and 32P radioactivity
phosphatase
radioactivity
showed
solubilized
phosphorylated line
BIOCHEMICAL
with
ATP
in the
from
the reacted
3(b)).
DISCUSSION In this
report
phorylation
are
purification present, level
we have studied involved
of the studies
are
alteration
adenylate
with
impossible. of the
in the
possibility
regulation
cyclase
purified
that
phosphorylation
of adenylate
system
molecules
Therefore activity
the
cyclase
is difficult
by incubation
this
analysis
enzyme
of plasma
activity.
to achieve
and detailed
we studied
and dephos-
for
the
at the molecular
system
membrane
As the
by investigating
with
the
ATP and phospha-
tase. While ing
incubation
of plasma
membrane
resulted
in a loss
of adenylate
system
ATP regenerating
system,
A non-phosphorylating 1).
Though
with
Richards
and Mg2+ prevented
analogue et al.
reported
ATP, ATP regenerating
system,
we did
not
observe
prepared
from other
cell
lines
(rat
cells)
by various
methods
normal yielded '52
ATP and ATP regenerat-
activity,
incubation
of activity
was not as effective
that
this
without
such a loss
incubation 2+ and Mg results
cyclase,
3Yl
cyclase
of ATP, AppNHp,
adenylate
formed
of S49 cells
stimulation. 3Yl cells similar
of rat
liver
in a 4-7
fold
Membrane and adenovirus results
(data
with (Fig.
ATP,
l(a)).
as ATP (Table plasma
membrane
activation
of
fractions type not
12-transshown).
Vol. 112, No. 1, 1983
BIOCHEMICAL
AND BIOPHYSICAL
Incubation
Time
RESEARCH COMMUNICATIONS
(hours)
Fig. 1. Effect of incubation with ATP and ATP regenerating system on adenylate cyclase activity. Plasma membranes of S49 cells (a), or cyccells (b) (1.5 mg protein/ml, final concentration) were incubated with 50 mM Hepes-NaOH pH 7.4, 1 mM ATP, 10 mg/ml phosphocreatine, 5 mg/ml phosphocreatine kinase, and 5 mM MgC12 (o), or with 50 mM Hepes-NaOH pH 7.4 and 5 mM MgC12 (A) at O'C and then diluted with 6 volumes of 20 mM Hepes-NaOH pH 7.4, and centrifuged at 100,000 x g for 30 min. The obtained membrane pellets were used for the assay of adenylate cyclase activity. 100% is 10.5 pmol/mg protein/min in (a) and 5.1 pmol/mg protein/min in (b).
('ne possible front adenylate without
interpretation cyclase
of these
by an endogenous
ATP and ATP regenerating
system
Table Incubation Condition
ATP (1 mM), AppNHp -
of
of
S49 cell
ATP regenerating
system system
is as follows:
phosphatase resulted
activity in the
Removal during
decrease
of phosphate
the
incubation
in adenylate
1 membranes adenylate pmol/mg
incubation
ATP regenerating
(1 mM),
plasma
results
with
ATP or
AppNHp
cyclase activity protein/min (X of initial
9.5
(96)
3.9
(39)
3.0
(30)
activity)
S49 cell plasma membranes (1.5 mg protein/ml, final concentration) were Incubated with 50 mM Hepes-NaOH pH 7.4, 5 mM MgC12, and other components for 20 h ~lt 0°C. Membranes were recovered from incubation and assayed for adenylate cyclase ~lctivity as described in Materials and Methods. ATP regenerating system consists of phosphocreatine and phosphocreatine kinase (final 10 mg/ml and 5 mg/ml, -espectively). The initial adenylate cyclase activity of the membrane preparation was 9.9 pmol/mg protein/min.
BIOCHEMICAL
Vol. 112, No. 1, 1983
(a)
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
(b)
549
P
P
o- -A---r-\
CYC-
p-
100'
A
-A
\
P 0
0 \ \
O\ 0
-------0
O-------O-
50
0
30
60
0
Incubation
Time
30
60
(minutes)
Fig. 2. Effect of alkaline phosphatase treatment on adenylate cyclase activity. Adenylate cyclase was solubilized from plasma membranes of S49 cells (a), or cyccells (b) (2.3 tng protein/ml) with 1% Triton NlOl as described in Materials and Methods. The solubilized adenylate cyclase (80 m protein) was reacted with 0.76 units of immobilized calf intestine alkaline phosphatase (0) or with agarose (L) at 0°C in a total volume of 100 ~1. After centrifugation the obtained supernatant was assayed for adenylate cyclase activity in the presence of 50 fl guanyl-5'-yl imidodiphosphate (a) or 5 mM MnCl (b). 100% is 12.4 pmol/mg protein/min in (a) and 7.3 pmol/mg protein/min in (b 5 .
cyclase by
activity.
an
and
When
endogenous
prevented This
was
phosphatase. the
In
memebrane: membrane.
observed
in
removal It
of is
kinase of
order
ATP
competed
adenylate
to
by exclude
regenerating
the
In
this
system,
1 with
the
suggest
that
the
the
were
added,
endogenous
phosphorylation
phosphatase
activity
activity.
effect an
system
with
cyclase
phospholipids,
paralle
results
and
supported
e.g.
plasma
These
protein a loss
model
ATP
of
effect we
dephosphorylation of
used
decrease
phosphatase
the
dephosphorylation activity
on
adenylate of
cyclase adenylate
of of
by
the
adenylate
added
other
components
solubilized cyclase
proteins cyclase
immobilized
from
activity (Fig.
can
of
was
2(a),
3(a)).
be changed
by
phosphate. known
components: and
a catalytic
the
component
that
adenylate
a hormone
receptor,
component involved
cyclase
in
systems
a guanine
(17,
18).
the
alteration
consist
of
at
nucleotide-binding
We employed of 254
cycadenylate
least
three
separable
regulatory mutant cyclase
S49
cells
activity
component, to by
identify the
Vol. 112, No. 1, 1983
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
(b)
0
30
60
CYC-
30
0
Incubation
Time
60
(minutes)
Fig. 3. Time course of dephosphorylation of 32P-labeled solubilized membrane proteins. Plasma membranes (2.3 mg protein/ml) were phosphorylated with [r32P]ATP and solubilized with 1% Triton NlOl as described in Materials and Methods. The solubilized adenylate cyclase (80 a protein) was incubated with 0.76 units of immobilized calf intestine alkaline phosphatase (0) or with agarose (A) at 0°C in a total volume of 100 ~1. At the indicated times samples were centrifuged and the supernatant was used for the determination of 2P radloactivity associated with proteins. (a) S49 (100% = 2101 cpm), (b) cyc(100% = 1902 cpm).
treatment
described
defective
guanine
to
stimulation
of
the
Using
of
these
the
vance
activity
of
hormone
The
by
the
the
assumed
to
be
indicate
of
protein
kinase
can
cyclase
remain
to
fication
and
of
and
protein
enhance be
or
measured
type
lymphoma
fluoride in
S49
(Fig.
component
site
of
action
the
activity
of of
and
of
Mn *+
cells
the
treatment.
The
catalytic
same
3(b)).
component, the
(10-13).
the
2(b),
cyc-
respond
activity
exhibit
l(b),
a
to
the
of
to
has
unable
presence shown
cells
is ion
the
was
cells
and
nucleotide-binding
has
no
rele-
the
catalytic
results
component
of
may
be
dephosphorylation. kinase
the
mouse
component
guanine
and
decreased Final
determined.
characterization
S49
component
catalytic
the
and the
be
wild
that
phosphorylation
identity
can
solubilized
receptors
of
nucleotides
catalytic
cyclase
experiments
gulated
mutant regulatory
alone
cells,
adenylate
was
cyc-
guanine
component mutant
component these
hormones,
as
to
The
nucleotide-binding
catalytic
response As
above.
of
the
whether
phosphorylation
activity proof catalytic
255
of of
the
by
a purified
dephosphorylated hypothesis
component
and
adenylate will
the
require protein
purikinase
re-
Vol. 112, No. 1, 1983
involved.
Analysis
of several specific
BIOCHEMICAL
of protein
memebrane-associated membrane
of adenylate
proteins
cyclase,
AND BIOPHYSICAL
kinases
of the plasma
protein (unpublished
characterization
kinases data). of these
RESEARCH COMMUNICATIONS
membrane
revealed
and each of which In relation protein
the presence
phosphorylated
to the phosphorylation kinases
is
under
investi-
gation. ACKNOWLEDGEMENTS We thank Y. Osawa, K. Tanaka, and A. Takayama for helpful technical assistance. This work is supported by the Institute of Microbial Chemistry and a Grant-in-aid for Cancer Research from the Ministry of Education, Science and Culture of Japan. REFERENCES 1. Krebs, E. G. and Beavo, J. A. (1979) Ann. Rev. Biochem. 48, 923-959 2. Cohen, P. (1982) Nature 296, 613-620 3. Constantopoulos, A. and Najjar, V. A. (1973) Biochem. Biophys. Res. Commun. 53, 794-799 A., Judge, J., Rauner, R. and Najjar, V. A. (1973) 4. Layne, P., Constantopoulos, Biochem. Biophys. Res. Commun. 2, 800-805 5. Richards, J. M. and Swislocki, N. I. (1979) J. Biol. Chem. 254, 6857-6860 6. Richards, J. M., Tierney, J. M. and Swislocki, N. I. (1981) J. Biol. Chem. 256, 8889-8891 7. Hollander, V. P. (1971) The Enzymes, pp. 450-498, Academic Press, New York 8. Dipietro, D. L. and Zengerle, F. S. (1967) J. Biol. Chem. 242, 3391-3396 9. Ikawa, T., Nishizawa, K. and Miwa, T. (1964) Nature 203, 939-940 10. Bourne, H. R., Coffino, P. and Tompkins, G. M. (1975)cience 187, 750-752 11. Ross, E. M. and Gilman, A. G. (1977) Proc. Natl. Acad. Sci. U.S.A. 74, 37153719 12. Ross, E. M., Howlett, A. C., Ferguson, K. M. and Gilman, A. G. (1978) J. Biol. Chem. 253, 6401-6412 13. Ferguson, K. M., Northup, J. K. and Gilman, A. G. (1982) Fed. Proc. fi, 1407 14. Courtneidge, S. A., Levinson, A. D. and Bishop, A. M. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 3783-3787 15. Salmon, Y., Londos, C. and Rodbell, M. (1974) Anal. Biochem. 58, 541-548 16. Cassel, D. and Glaser, L. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 2231-2235 17. Rodbell, M. (1980) Nature 284, 17-22 18. Ross, E. M. and Gilman, A. G. (1980) Ann. Rev. Biochem. 49-, 533-564
‘56